| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Shannon John Patrick Jr serves as a See Remarks at XERS. Across recent SEC filings that breaks down to 3 buys and 2 sells. Those positions are worth an estimated $23.4M at current prices.
Historically, Shannon John Patrick Jr's trades have earned a middling insider score of 53/100 across 5 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +1.8%.
The biggest single holding is XERS (~$23.4M) as See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 82,620 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sale+OE | 24,907 | $7.08 | $176,256.88 | -0.9% | -14.7% | - | |
| Nov 13, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sale+OE | 23,242 | $7.46 | $173,401.59 | -0.9% | -4.8% | - | |
| Nov 17, 2023 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Buy | 30,769 | $1.64 | $50,399.62 | +2.2% | +81.4% | +65.0% | |
| Nov 12, 2021 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Buy | 100,000 | $2.10 | $209,500.00 | +37.9% | +16.4% | -30.8% |